Feed aggregator

Marathon Asset Management Appoints Murad Khaled as a Lead Originator for European ABL and Direct Lending

Lastest from Businesswire - Fri, 04/17/2026 - 08:15
NEW YORK & LONDON--(BUSINESS WIRE)--Marathon Asset Management, a leading global credit manager, today announced that Murad Khaled has joined the firm as a Managing Director, where he will serve as a lead originator across ABL and DL in Europe, reporting to Alex Howell, Head of Marathon's European Credit business. Mr. Khaled joins Marathon from Apollo, where he was a Managing Director and led Capital Solutions in Europe. Prior to Apollo, Mr. Khaled served as Head of EMEA Leveraged Finance Capita

Informa TechTarget to Announce First Quarter 2026 Financial Results; Participate in Upcoming Investor Conferences

Lastest from Businesswire - Fri, 04/17/2026 - 08:15
NEWTON, Mass.--(BUSINESS WIRE)--TechTarget, Inc. (Nasdaq: TTGT) (“Informa TechTarget” or the “Company”), a leading growth accelerator for the B2B Technology sector, today announced the date for the release of its financial results for the first quarter ended March 31, 2026, and its participation in upcoming investor conferences. First Quarter 2026 Earnings: Informa TechTarget will release its first quarter 2026 financial results after the market closes on Thursday, May 7, 2026. The Company’s Ch

Western Asset High Yield Opportunity Fund Inc. (NYSE: HYI) Announces Portfolio Management Team Update

Lastest from Businesswire - Fri, 04/17/2026 - 08:15
NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement

Western Asset Diversified Income Fund (NYSE: WDI) Announces Portfolio Management Team Update

Lastest from Businesswire - Fri, 04/17/2026 - 08:15
NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement

Western Asset Global High Income Fund Inc. (NYSE: EHI) Announces Portfolio Management Team Update

Lastest from Businesswire - Fri, 04/17/2026 - 08:15
NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement

Franklin Templeton Closed-End Funds Announce Share Repurchases for the First Quarter of 2026

Lastest from Businesswire - Fri, 04/17/2026 - 08:15
NEW YORK--(BUSINESS WIRE)--Category: Corporate Action

Western Asset Premier Bond Fund (NYSE: WEA) Announces Portfolio Management Team Update

Lastest from Businesswire - Fri, 04/17/2026 - 08:15
NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement

Corebridge Financial Elects Hirotaka Inoue to Board of Directors

Lastest from Businesswire - Fri, 04/17/2026 - 08:15
HOUSTON--(BUSINESS WIRE)--Corebridge Financial, Inc. (NYSE: CRBG) today announced that its Board of Directors elected Hirotaka Inoue as a director effective April 21, 2026. Mr. Inoue will serve as a Nippon Life Insurance Company-designated director and will replace Minoru Kimura, who will depart from the Board effective April 20, 2026. “We are pleased to welcome Hirotaka Inoue to the Corebridge Board,” said Alan Colberg, Chair of the Board of Corebridge Financial. “Hiro brings deep expertise in

Western Asset High Income Fund II Inc. (NYSE: HIX) Announces Portfolio Management Team Update

Lastest from Businesswire - Fri, 04/17/2026 - 08:15
NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement

Franklin Universal Trust (“FT” or the “Fund”) Announces Portfolio Management Team Update

Lastest from Businesswire - Fri, 04/17/2026 - 08:15
SAN MATEO, Calif.--(BUSINESS WIRE)--Franklin Universal Trust [NYSE: FT] today announced a Portfolio Management Team update. Effective June 30, 2026, the named portfolio management team responsible for the day-to-day oversight of the Fund is as follows: Glenn Voyles Jon Belk Robert L. Salvin Bryant Dieffenbacher Data and commentary provided in this press release are for informational purposes only. Franklin Resources and its affiliates do not engage in selling shares of the Fund. The Fund’s shar

State Street Corporation (NYSE: STT) Reports First-Quarter 2026 Financial Results

Lastest from Businesswire - Fri, 04/17/2026 - 08:15
BOSTON--(BUSINESS WIRE)--State Street Corporation (NYSE: STT) reported its first-quarter 2026 financial results today. The news release, presentation and additional financial information can be accessed on State Street’s Investor Relations website, http://investors.statestreet.com. A conference call to discuss the firm’s financial results, outlook and related matters will be held at 11:00 a.m. ET today, Friday, April 17, 2026. The call will be open to the public. The conference call will be acc

Summer Road Calls on the Board of Ingles Markets to Stop Wasting Shareholder Resources on Fabricated Issues to Mislead Shareholders

Lastest from Businesswire - Fri, 04/17/2026 - 08:15
WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Summer Road LLC (“Summer Road” or “we”) today issued the following statement in response to Ingles Markets, Incorporated’s (NASDAQ: IMKTA) (“Ingles” or the “Company”) repeated dishonest and misleading public statements. “The Company’s daily, disjointed attacks on Summer Road should make shareholders question the judgment of the incumbent Board and its vehement opposition to the election of a truly independent Class A shareholder voice. To suggest that Ror

Fifth Third Bancorp Reports First Quarter 2026 Earnings

Lastest from Businesswire - Fri, 04/17/2026 - 08:15
CINCINNATI--(BUSINESS WIRE)--Fifth Third Bancorp (NASDAQ: FITB): Key Financial Data             Key Highlights                         $ in millions for all balance sheet and income statement items                   1Q26 4Q25 1Q25 Successfully closed Comerica acquisition Opening Balances as of February 1st: Total assets, including goodwill, of $86 billion Total loans of $51 billion Total deposits of $65 billion   Stability: Solid credit performance. Net charge-offs(b) of 37 bps in 1Q26; lowest s

Regions Reports earnings of $539 million and EPS of $0.62 in 1Q 2026

Lastest from Businesswire - Fri, 04/17/2026 - 08:15
BIRMINGHAM, Ala.--(BUSINESS WIRE)--Regions Financial Corp. (NYSE:RF) today reported first quarter 2026 earnings of $539 million and diluted EPS of $0.62.

Orthogon Therapeutics Raises an Additional $11M Financing for Its BK Virus Antiviral Drug Program

Lastest from Businesswire - Fri, 04/17/2026 - 05:15
CANTON, Mass.--(BUSINESS WIRE)-- #BKV--Orthogon Therapeutics today announced the closing of a follow-on $11 million financing, bringing its total capital raised to $36 million. This financing supports the continued advancement of its first-in-class drug against BK polyomavirus. BK virus infections are a major cause of complications in transplant patients, with no approved treatments. The company is pioneering an oral therapy that addresses the full spectrum of BK infection, from early reactivation thr

Pages